Related Experiment Video
Updated: Jun 17, 2026
03:07
Single-Port Robotic-assisted Transaxillary Breast-conserving Surgery: A Prospective, Single-arm, Non-randomized Phase IIa Clinical Trial
Published on: August 19, 2025
SCOUT MD™ for breast and axillary localisation: a narrative review toward a single radar-based platform
1The London Breast Institute, Princess Grace Hospital, London, UK.
Gland Surgery
|June 16, 2026
Summary
Next-generation radar localization (SCOUT MD™) uses unique signals for multiple targets, improving on older systems. More clinical studies are needed to confirm its effectiveness in breast lesion localization.
Area of Science:
- Medical Imaging
- Surgical Navigation
- Biomedical Engineering
Background:
- Wire-free localization technologies have revolutionized breast cancer management.
- Radar-based localization, like the SAVI SCOUT® system, has strong clinical support.
- SCOUT MD™ is a new radar platform with advanced reflectors for improved localization.
Purpose of the Study:
- To review the technical aspects, regulatory standing, and clinical data for SCOUT MD™.
- To position SCOUT MD™ within the field of wireless localization technologies.
Main Methods:
- A narrative review of literature from January 2016 to January 2026.
- Included PubMed-indexed articles, regulatory documents, and manufacturer reports.
- Focused on radar-based localization systems.
Main Results:
- SCOUT MD™ features 5-mm reflectors with unique, multi-target radar signatures.
- The system allows individual reflector discrimination without signal overlap.
- Deployment is supported by ultrasound, stereotactic mammography, MRI, and CT.
Conclusions:
- SCOUT MD™ overcomes limitations of single-reflector systems, especially for multi-target localization.
- Current clinical evidence is preliminary, with early technical reports and one case study.
- Further prospective studies are necessary to validate its comparative effectiveness.
